21-31120504-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM5BP4_StrongBS2
The NM_001353694.2(TIAM1):c.4640C>T(p.Ala1547Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000923 in 1,614,182 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A1547E) has been classified as Pathogenic.
Frequency
Consequence
NM_001353694.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TIAM1 | NM_001353694.2 | c.4640C>T | p.Ala1547Val | missense_variant | 28/28 | ENST00000541036.6 | NP_001340623.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TIAM1 | ENST00000541036.6 | c.4640C>T | p.Ala1547Val | missense_variant | 28/28 | 5 | NM_001353694.2 | ENSP00000441570 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000175 AC: 44AN: 251378Hom.: 1 AF XY: 0.000265 AC XY: 36AN XY: 135846
GnomAD4 exome AF: 0.0000937 AC: 137AN: 1461890Hom.: 5 Cov.: 30 AF XY: 0.000150 AC XY: 109AN XY: 727244
GnomAD4 genome AF: 0.0000788 AC: 12AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000940 AC XY: 7AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | The c.4640C>T (p.A1547V) alteration is located in exon 29 (coding exon 25) of the TIAM1 gene. This alteration results from a C to T substitution at nucleotide position 4640, causing the alanine (A) at amino acid position 1547 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at